Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-26-008802

CVP, TAVR sold 619 shares at $104.25 ($64,531)

  • CVP, TAVR acquired 619 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Lippis Daniel J. CVP, TAVR 2026-11-10 Option exercise 10b5-1 +619 $72.68 $44,989 40,652.91 D
Lippis Daniel J. CVP, TAVR 2026-11-10 Sale 10b5-1 −619 $104.25 $64,531 40,033.91 D
Derivatives
Lippis Daniel J. CVP, TAVR 2026-11-10 Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 −619 2,476 D
Open-market sales · 619 sh · avg $104.25 · $64,531
Loading xslF345X06/doc4.xml…